Get the Stockscreener App
1.64
4.65%
-0.08
Pre-market:
1.68
0.04
+2.44%
Opko Health Inc stock is traded at $1.64, with a volume of 2.07M.
It is down -4.65% in the last 24 hours and up +10.81% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
See More
Previous Close:
$1.72
Open:
$1.73
24h Volume:
2.07M
Relative Volume:
0.60
Market Cap:
$1.10B
Revenue:
$711.41M
Net Income/Loss:
$-133.73M
P/E Ratio:
-8.6316
EPS:
-0.19
Net Cash Flow:
$-199.99M
1W Performance:
-4.65%
1M Performance:
+10.81%
6M Performance:
+1.86%
1Y Performance:
+73.36%
1-Day Range:
$1.63
$1.73
1-Week Range:
$1.63
$1.74
52-Week Range:
$0.8601
$1.76
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.64 | 1.10B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
539.55 | 203.55B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.41 | 150.38B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
134.18 | 38.28B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
459.86 | 37.40B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
190.97 | 33.63B | 15.41B | 1.37B | 2.11B | 7.50 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
Countdown to OPKO Health (OPK) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
OPKO Health (OPK) to Release Earnings on Thursday - MarketBeat
OPKO Health Target of Unusually Large Options Trading (NASDAQ:OPK) - MarketBeat
OPKO Health (OPK) Expected to Announce Earnings on Thursday - MarketBeat
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains - MSN
OPKO Health to Announce Q4 2024 Financial Results - TipRanks
OPKO Health, Inc. to Report Q4 and Full Year 2024 Financial Results on February 27, 2025 - Nasdaq
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025 - GlobeNewswire
OPKO Health Sets Critical Q4 Earnings Date: What The Numbers Will Reveal - StockTitan
Hidden Gems of Nasdaq: Why These Under-$5 Stocks Are Catching Eye - MotoPaddock
Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy? - Insider Monkey
10 Best Nasdaq Stocks Under $5 to Buy - Insider Monkey
Y.D. More Investments Ltd Has $2.06 Million Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health (NASDAQ:OPK) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Insiders continue to buy OPKO Health, Inc. (NASDAQ:OPK) and now own 52% shares - Simply Wall St
Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud - Grizzly Reports
OPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 47,537 Shares - MarketBeat
Opko health CEO Phillip Frost buys $70,060 in stock By Investing.com - Investing.com Australia
Opko health CEO Phillip Frost buys $70,060 in stock - MSN
Clinical Laboratory Tests Market Generated Opportunities, - openPR
Clinical Laboratory Tests Market Key Players AnalysisARUP - openPR
OPKO Health, Inc. (NASDAQ:OPK) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Billionaire Phillip Frost's health care company settles case with federal government - The Business Journals
OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - Insider Monkey
12 Stocks Under $5 With Biggest Upside Potential - Insider Monkey
Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN
3 Stocks That Wall Street Insiders Can't Stop Buying - MSN
BioReference faces $704,349 fine for medically unnecessary blood tests - MSN
Opko health CEO Phillip Frost buys $220,425 in common stock - MSN
OPKO Health : Immediate Report -January 18, 2025 at 06:29 am EST - Marketscreener.com
Opko health CEO Phillip Frost buys $220,425 in common stock By Investing.com - Investing.com Canada
Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat
BioReference Health and OPKO Health Agree to Pay $704,349 to Settle Allegations that they Billed the - U.S. Politics Today
BioReference Health, OPKO Health Settle False Claims Violations - Bloomberg Law
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.50%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):